- Home
- PRLD vs SPAI Comparison
PRLD vs SPAI Comparison
Compare PRLD & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- SPAI
- Stock Information
- Founded
- PRLD 2016
- SPAI 2021
- Country
- PRLD United States
- SPAI United States
- Employees
- PRLD N/A
- SPAI N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- SPAI Industrial Specialties
- Sector
- PRLD Health Care
- SPAI Health Care
- Exchange
- PRLD Nasdaq
- SPAI Nasdaq
- Market Cap
- PRLD 44.0M
- SPAI 38.5M
- IPO Year
- PRLD 2020
- SPAI 2024
- Fundamental
- Price
- PRLD $1.19
- SPAI $7.49
- Analyst Decision
- PRLD Strong Buy
- SPAI Strong Buy
- Analyst Count
- PRLD 3
- SPAI 2
- Target Price
- PRLD $4.00
- SPAI $10.50
- AVG Volume (30 Days)
- PRLD 223.1K
- SPAI 406.7K
- Earning Date
- PRLD 11-05-2025
- SPAI 08-14-2025
- Dividend Yield
- PRLD N/A
- SPAI N/A
- EPS Growth
- PRLD N/A
- SPAI N/A
- EPS
- PRLD N/A
- SPAI N/A
- Revenue
- PRLD $7,000,000.00
- SPAI $1,496,091.00
- Revenue This Year
- PRLD N/A
- SPAI N/A
- Revenue Next Year
- PRLD N/A
- SPAI N/A
- P/E Ratio
- PRLD N/A
- SPAI N/A
- Revenue Growth
- PRLD N/A
- SPAI 7.49
- 52 Week Low
- PRLD $0.61
- SPAI $1.47
- 52 Week High
- PRLD $5.53
- SPAI $7.60
- Technical
- Relative Strength Index (RSI)
- PRLD 56.86
- SPAI 69.35
- Support Level
- PRLD $1.10
- SPAI $6.16
- Resistance Level
- PRLD $1.26
- SPAI $7.08
- Average True Range (ATR)
- PRLD 0.15
- SPAI 0.95
- MACD
- PRLD -0.00
- SPAI 0.08
- Stochastic Oscillator
- PRLD 70.65
- SPAI 96.92
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.